Page last updated: 2024-10-28

hydralazine and Pancytopenia

hydralazine has been researched along with Pancytopenia in 3 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KAUFMAN, M1
EVANS, JA1
EISENBEIS, CH1
Stewart, GW1
Peart, WS1
Boylston, AW1

Other Studies

3 other studies available for hydralazine and Pancytopenia

ArticleYear
Pancytopenia following use of hydrallazine (apresoline).
    Journal of the American Medical Association, 1953, Apr-25, Volume: 151, Issue:17

    Topics: Anemia; Anemia, Aplastic; Hydralazine; Hypertension; Pancytopenia; Sympatholytics; Tracheophyta

1953
1-Hydrazinophthalazine (apresoline) toxicity; report of a case of arthritis of the rheumatoid type and pancytopenia.
    The Lahey Clinic bulletin, 1955, Volume: 9, Issue:4

    Topics: Anemia; Anemia, Aplastic; Arthritis; Arthritis, Rheumatoid; Hydralazine; Hypertension; Pancytopenia;

1955
Obstructive jaundice, pancytophenia and hydralazine.
    Lancet (London, England), 1981, May-30, Volume: 1, Issue:8231

    Topics: Cholestasis; Humans; Hydralazine; Hypertension; Male; Middle Aged; Pancytopenia

1981